BGM Group Ltd.

Healthcare

NASDAQ:BGM · NASDAQ Global Market

Market Cap $72.63M Beta 1.82 P/E (TTM) -1.9

$0.38 +9.78%

+$0.03 today

52W Low $0.26High $15.53

Vol 0.42M · Avg 0.48M

EPS (TTM)-$0.20

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-97.22%

Period High

$14.10

Period Low

$0.26

Latest

$0.38

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Twist Bioscience Corporation

NASDAQ:TWST

$4.74B

Edgewise Therapeutics, Inc.

NASDAQ:EWTX

$3.75B

Structure Therapeutics Inc.

NASDAQ:GPCR

$2.47B

Clover Health Investments, Corp.

NASDAQ:CLOV

$2.45B

Avadel Pharmaceuticals plc

AVDL

$2.12B

ANI Pharmaceuticals, Inc.

NASDAQ:ANIP

$1.86B

Mesoblast Limited

NASDAQ:MESO

$1.79B

PROCEPT BioRobotics Corporation

NASDAQ:PRCT

$1.46B

Phibro Animal Health Corporation

NASDAQ:PAHC

$1.28B

QuidelOrtho Corporation

NASDAQ:QDEL

$963.54M

What is the latest BGM filing?

The latest filing shown is 6-K dated May 18, 2026.

How many recent filings does BGM have?

Intrinsic Alpha currently shows 20 recent filings for BGM.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.